Breast cancer could be classified into multiple molecular subtypes according to various criteria, based on expression of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) or transcription of PAM50 gene signatures.2 This evidence concerns the gene ERBB2 and breast cancer.